Literature DB >> 9237195

In vitro selection methodologies to probe RNA function and structure.

R C Conrad1, S Baskerville, A D Ellington.   

Abstract

In vitro selection, or SELEX, has been used both to characterize the interaction of natural nucleic acids with proteins and to generate novel nucleic acid-binding species, or aptamers. Although numerous reports have demonstrated the power of the technique, they have not expanded on the methodologies that can be used for selection. This review focuses on the considerations and problems involved in selecting protein-binding aptamers from a random-sequence RNA pool. As an illustration, we describe two approaches to selecting aptamers to a particular target, the HTLV-I Rex protein. In the first, complete randomization is used to find an artificial, high-affinity RNA binding site. In the second, the contributions of individual nucleotides and/or base pairs to the natural Rex-binding element are determined by mutating the wild-type sequence and selecting active binding variants.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9237195     DOI: 10.1007/bf01715810

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  48 in total

1.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin.

Authors:  L C Bock; L C Griffin; J A Latham; E H Vermaas; J J Toole
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

2.  The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine.

Authors:  J A Latham; R Johnson; J J Toole
Journal:  Nucleic Acids Res       Date:  1994-07-25       Impact factor: 16.971

3.  Selection of high-affinity RNA ligands to reverse transcriptase: inhibition of cDNA synthesis and RNase H activity.

Authors:  H Chen; L Gold
Journal:  Biochemistry       Date:  1994-07-26       Impact factor: 3.162

4.  Selective enrichment of RNA species for tight binding to Escherichia coli rho factor.

Authors:  D Schneider; L Gold; T Platt
Journal:  FASEB J       Date:  1993-01       Impact factor: 5.191

Review 5.  Aptamers as potential nucleic acid pharmaceuticals.

Authors:  A D Ellington; R Conrad
Journal:  Biotechnol Annu Rev       Date:  1995

6.  In vitro selection of nucleic acid aptamers that bind proteins.

Authors:  R C Conrad; L Giver; Y Tian; A D Ellington
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

7.  Evolution in vitro: sequence and phenotype of a mutant RNA resistant to ethidium bromide.

Authors:  F R Kramer; D R Mills; P E Cole; T Nishihara; S Spiegelman
Journal:  J Mol Biol       Date:  1974-11-15       Impact factor: 5.469

Review 8.  Diversity of oligonucleotide functions.

Authors:  L Gold; B Polisky; O Uhlenbeck; M Yarus
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

9.  PCR with detachable primers.

Authors:  M H Silveira; L E Orgel
Journal:  Nucleic Acids Res       Date:  1995-03-25       Impact factor: 16.971

10.  In vitro selection of RNA aptamers specific for cyanocobalamin.

Authors:  J R Lorsch; J W Szostak
Journal:  Biochemistry       Date:  1994-02-01       Impact factor: 3.162

View more
  12 in total

Review 1.  Imaging gene expression: principles and assays.

Authors:  S S Gambhir; J R Barrio; H R Herschman; M E Phelps
Journal:  J Nucl Cardiol       Date:  1999 Mar-Apr       Impact factor: 5.952

Review 2.  RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.

Authors:  Peixuan Guo
Journal:  J Nanosci Nanotechnol       Date:  2005-12

3.  ZBP2 facilitates binding of ZBP1 to beta-actin mRNA during transcription.

Authors:  Feng Pan; Stefan Hüttelmaier; Robert H Singer; Wei Gu
Journal:  Mol Cell Biol       Date:  2007-09-24       Impact factor: 4.272

4.  Combinatorial library diversity: probability assessment of library populations.

Authors:  B Ward; T Juehne
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

5.  Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope.

Authors:  W Xu; A D Ellington
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

6.  Selection of RNA aptamers imported into yeast and human mitochondria.

Authors:  Olga Kolesnikova; Helena Kazakova; Caroline Comte; Sergey Steinberg; Piotr Kamenski; Robert P Martin; Ivan Tarassov; Nina Entelis
Journal:  RNA       Date:  2010-03-26       Impact factor: 4.942

7.  Selection of bead-displayed, PNA-encoded chemicals.

Authors:  Natalie R Gassman; J Patrick Nelli; Samrat Dutta; Adam Kuhn; Keith Bonin; Zbigniew Pianowski; Nicolas Winssinger; Martin Guthold; Jed C Macosko
Journal:  J Mol Recognit       Date:  2010 Sep-Oct       Impact factor: 2.137

Review 8.  Engineering RNA for targeted siRNA delivery and medical application.

Authors:  Peixuan Guo; Oana Coban; Nicholas M Snead; Joe Trebley; Steve Hoeprich; Songchuan Guo; Yi Shu
Journal:  Adv Drug Deliv Rev       Date:  2010-03-15       Impact factor: 15.470

9.  Autoimmune epitopes in messenger RNA.

Authors:  Barbara D Lipes; Jack D Keene
Journal:  RNA       Date:  2002-06       Impact factor: 4.942

10.  Creation of RNA molecules that recognize the oxidative lesion 7,8-dihydro-8-hydroxy-2'-deoxyguanosine (8-oxodG) in DNA.

Authors:  S M Rink; J C Shen; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.